跳至主要内容
临床试验/NCT03616652
NCT03616652已完成不适用

Non-deceptive Application of Placebos in Insomnia

Philipps University Marburg Medical Center1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2018年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
1
主要终点
Self-reported Total Sleep Time

研究概览

简要总结

The purpose of this study is to evaluate whether non-deceptive application of a placebo has an impact on subjective or objective sleep parameters in patients with primary insomnia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age between 18 years to 69 years
  • fluent in German language
  • provide written informed consent
  • ability to understand the explanations and instructions given by the study physician and the investigator

排除标准

  • evidence for sleep disorders caused by medical factors (e.g. sleep apnea, restless legs syndrome, narcolepsy, substance-induced insomnia)
  • allergies to ingredients of placebo
  • patients scoring below 8 or above 21 on the Insomnia Severity Index
  • patients suffering from a mental disorder as verified by the SCID
  • patients suffering from an acute physical illness
  • nicotine consumption > 10 cigarettes/day
  • unwillingness to refrain from alcohol consumption throughout the study
  • change in concomitant medication regime during the last 2 weeks prior to visit 1 or after randomization
  • intake of psychotropic drugs during the last 3 months prior to visit 1
  • currently pregnant (verified by urine pregnancy test) or lactating

研究组 & 干预措施

Non-deceptive placebo group (additional information)

Experimental

Participants receive a placebo pill and are told that it is placebo. They receive additional information about the power of placebo effects via a film sequence before they take the placebo.

干预措施: Placebo (Drug)

Non-deceptive placebo group (additional information)

Experimental

Participants receive a placebo pill and are told that it is placebo. They receive additional information about the power of placebo effects via a film sequence before they take the placebo.

干预措施: Film sequence (Other)

Non-deceptive placebo group (no additional information)

Placebo Comparator

Participants receive a placebo pill and are told that it is placebo. They do not receive additional information about placebo effects. Instead, they watch a neutral film sequence about sleep.

干预措施: Placebo (Drug)

Non-deceptive placebo group (no additional information)

Placebo Comparator

Participants receive a placebo pill and are told that it is placebo. They do not receive additional information about placebo effects. Instead, they watch a neutral film sequence about sleep.

干预措施: Film sequence (Other)

结局指标

主要结局

Self-reported Total Sleep Time

时间窗: change from baseline to 1 night after placebo intake

assessed by sleep diary

次要结局

  • Objective Sleep Onset Latency(change from baseline to 1 night after placebo intake)
  • Objective Total Sleep Time(change from baseline to 1 night after placebo intake)
  • Objective Sleep Efficiency(change from baseline to 1 night after placebo intake)
  • Self-reported Sleep Onset Latency(change from baseline to 1 night after placebo intake)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Winfried Rief

Professor Dr.

Philipps University Marburg Medical Center

研究点 (1)

Loading locations...

相似试验